PleuraFlow ACT
Commercial- Indications
- Retained Blood Syndrome, Postoperative atrial fibrillation, Cardiac surgery complications
Company intelligence / Profile preview
ClearFlow (formerly Clear Catheter Systems) is a medical device company that develops and commercializes proprietary active clearance technologies to improve outcomes for patients undergoing surgery. The company's flagship product, the PleuraFlow Active Tube Clearance System, is designed to prevent chest tube clogging and the subsequent retention of blood and fluid in the chest cavity, a condition known as Retained Blood Syndrome (RBS). By proactively maintaining tube patency, ClearFlow's technology reduces the need for secondary interventions, lowers hospital costs, and improves patient recovery after cardiothoracic and other surgical procedures. Headquartered in Irvine, California, the company is focused on expanding its anti-clogging platform into other clinical areas such as urinary drainage and enteral feeding.
1 more asset in the full pipeline.
Request access →Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Clear Catheter Systems.